
m_and_aJohannesburgAfrivestia
Sibanye-Stillwater and Necsa target next-gen precision cancer therapies with rhodium
Sibanye-Stillwater and Necsa target next-gen precision cancer therapies with rhodium Bizcommunity
Related stocks
Related stories
Tharisa Secures New R750m Asset Revolving Finance Facility from Nedbank
Tharisa secures new R750m asset revolving finance facility from Nedbank Engineering News
Tharisa secures new $45 million facility with Nedbank to support underground mining
Tharisa secures a $45 million facility from Nedbank to enhance its underground mining operations.
Nedbank backs Tharisa’s first underground mining fleet with R750m facility
Nedbank provides R750 million facility to support Tharisa's first underground mining fleet.